tiprankstipranks
Trending News
More News >
Northwest Biotherapeutics (NWBO)
:NWBO

Northwest Biotherapeutics (NWBO) Revenue

Compare
502 Followers

Northwest Biotherapeutics Revenue

Northwest Biotherapeutics had a revenue of 375.00K in the quarter ending Mar 31, 2025, with 62.34%. This bring the company's revenue in the last twelve months to 1.47M, Decreased 6.58%. In the fiscal year ending Dec 31, 2024, Northwest Biotherapeutics had annual revenue of 1.38M with -28.47% growth.
Revenue (ttm)
1.47M
Revenue Growth
P/S Ratio
235.26
Revenue/Employee
$55,280
Employees
25
Market Cap
$325.13M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
1.38M-550.00K-28.47%
Dec 31, 2023
1.93M249.00K+14.80%
Dec 31, 2022
1.68M678.00K+67.46%
Dec 31, 2021
1.00M-286.00K-22.15%
Dec 31, 2020
1.29M-1.12M-46.43%
Dec 31, 2019
2.41M2.00M+484.95%
Dec 31, 2018
412.00K76.00K+22.62%
Dec 31, 2017
336.00K-287.00K-46.07%
Dec 31, 2016
623.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis